您當(dāng)前的位置:檢測(cè)資訊 > 法規(guī)標(biāo)準(zhǔn)
嘉峪檢測(cè)網(wǎng) 2025-01-10 17:36
歐盟醫(yī)療器械注冊(cè)臨床評(píng)價(jià)主要參考法規(guī)
|
文件名稱 |
產(chǎn)品類別 |
MDR |
支持性文件 |
|
TD
TECHNICAL DOCUMENTATION 技術(shù)文檔 |
All
|
ANNEX II
|
Best Practice Guidance for the Submission of Technical Documentation under Annex II and III of Medical Device Regulation (EU) 2017/745 |
|
CEP
Clinical Evaluation Plan 臨床評(píng)價(jià)計(jì)劃 |
All
|
ANNEX XIV PART A
|
MDCG 2020-6 Appendix II – Clinical Evaluation Plan for Legacy Devices
|
|
PMCF Plan
Post-market clinical follow-up Plan 上市后臨床跟蹤計(jì)劃 |
All
|
ANNEX XIV PART B
|
MDCG 2020-7
|
|
PMCF Evaluation Report
Post-market clinical follow-up (PMCF) Evaluation Report 上市后臨床跟蹤報(bào)告 |
All
|
Annex XIV Part B
|
MDCG-2020-8
|
|
PMS Plan
Post-market surveillance Plan 上市后監(jiān)督計(jì)劃 |
All
|
Article 84
|
ISO 20416
|
|
PMS Report
Post-market surveillance report 上市后監(jiān)督報(bào)告 |
ClassⅠ
|
Article 85
|
/
|
|
PSUR
Periodic safety update reports 定期安全更新報(bào)告 |
class IIa, class IIb and class III |
Article 86
|
MDCG-2022-21
|
|
CECP
Clinical Evaluation Consultation Procedure 臨床評(píng)估咨詢程序
|
class III implantable devices, class IIb active devices intended to administer and/or remove a medicinal product, as referred to in Section 6.4 of Annex VIII (Rule 12). |
Article 54
|
MDCG 2019-3
|
|
Summary of safety and clinical performance 安全和臨床性能總結(jié) |
Implantable devices and for class III devices |
Article 32
|
MDCG 2019-9 Rev.1
|

來(lái)源:醫(yī)械鐵鍋燉